Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and ...
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022
Source: eagletribune.com
📰 Dydo Pharma Inc News
Dydo Pharma Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dydo Pharma Inc. Real-time updates on events, politics, business and more.
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
29.02.2024 - Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total Revenues of $110.6 Million, an 82.0% Increase Compared to Fourth Quarter 2022 Reported 2023 GAAP ...
Source: wallstreet-online.de
Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma
CORAL GABLES, Fla., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") CPRX, a commercial-stage biopharmaceutical company focused…
Source: biztoc.com